Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial - Strojek, K; Yoon, K H; Hruba, V (Diabetes Obes Metab, 2011)
et al.